Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An epidemic model with fatal risk

C Lefèvre1, P Picard

  • 1Institut de Statistique, Université Libre de Bruxelles, Belgium.

Mathematical Biosciences
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world comparison of treatments with antibodies targeting the CGRP pathway or botulinum toxin type A for resistant migraine.

Revue neurologique·2025
Same author

Key domains involved in the interaction and assembly of the HCMV terminase complex.

Scientific reports·2025
Same author

Deciphering letermovir's mode of action and resistance mutation effects.

Antiviral research·2025
Same author

Impact of age in the healing time in myocutaneous and perforator flaps for pelvic pressure ulcers in patients with spinal cord injury.

The journal of spinal cord medicine·2025
Same author

Switching from onabotulinum toxin A to abobotulinum toxin A for treating detrusor overactivity in spinal cord injured patient, does it really work?

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

[Should we interfere with the interleukin-6 receptor during COVID-19: What do we know?]

Revue des maladies respiratoires·2022

A novel epidemic model accounts for fatal risk in infectious disease spread, encompassing both immunity-conferring and inevitably fatal diseases. It analyzes epidemic dynamics, threshold phenomena, and the impact of mortality rates.

Area of Science:

  • Epidemiology
  • Mathematical Biology
  • Infectious Disease Modeling

Background:

  • Understanding infectious disease dynamics is crucial for public health interventions.
  • Existing models often simplify disease outcomes, such as assuming complete immunity or inevitable fatality.

Purpose of the Study:

  • To develop a comprehensive epidemic model incorporating fatal risk.
  • To analyze the temporal and final states of epidemics under varying fatality levels.
  • To investigate the threshold phenomenon and the qualitative impact of fatal risk on disease spread.

Main Methods:

  • Development of a new mathematical model for infectious disease spread.
  • Inclusion of parameters representing fatal risk.
  • Examination of both deterministic and stochastic model versions.

Related Experiment Videos

  • Analysis of epidemic trajectories, equilibrium states, and threshold conditions.

    • Main Results:

    • The model successfully integrates standard epidemic and fatal epidemic processes as limiting cases.
    • Analysis reveals the influence of fatal risk on epidemic duration and final size.
    • The existence of a threshold phenomenon is confirmed, dependent on disease parameters and fatality.

    Conclusions:

    • The developed model provides a more realistic framework for studying infectious diseases with potential for mortality.
    • Fatal risk significantly alters epidemic dynamics, affecting spread patterns and outcomes.
    • The model aids in predicting epidemic behavior and informing public health strategies for diseases with varying severity.